CIK 0001527352 · <br>Emerging growth company
Nexalin Technology, Inc.
Sign in to watch- Ticker
- NXL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275566468
- Phone
- (832) 260-0222
- Business address
- 1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 4 Grant or award 10% owner acquired 83,333 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 36,459 shares (grant or award)
- 4 Grant or award Director acquired 36,459 shares (grant or award)
- 4 Grant or award Director acquired 36,459 shares (grant or award)
- 10-K/A Report 10-K/A
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Other events
- 25-NSE Other Notification of Removal from Listing
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- UPLOAD Other SEC-generated Letter
- 144 Insider Sale of Securities
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 8-K Event Executive or director change
Page 3 of 11 · 206 filings